Vivani Medical, Inc.
VANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $357 | $0 | $0 |
| Gross Profit | $0 | -$357 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $15,745 | $16,968 | $14,169 | $11,002 |
| G&A Expenses | $8,932 | $9,997 | $5,372 | $2,321 |
| SG&A Expenses | $8,932 | $9,997 | $5,372 | $2,321 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$357 | $1,700 | $0 |
| Operating Expenses | $24,677 | $26,608 | $21,241 | $13,323 |
| Operating Income | -$24,677 | -$26,965 | -$21,241 | -$13,323 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,191 | $1,313 | $7,352 | $550 |
| Pre-Tax Income | -$23,486 | -$25,652 | -$13,889 | -$12,773 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23,486 | -$25,652 | -$13,889 | -$12,773 |
| % Margin | – | – | – | – |
| EPS | -0.43 | -0.5 | -0.17 | -0.33 |
| % Growth | 14% | -194.1% | 48.5% | – |
| EPS Diluted | -0.43 | -0.5 | -0.17 | -0.33 |
| Weighted Avg Shares Out | 54,981 | 50,853 | 38,241 | 36,251 |
| Weighted Avg Shares Out Dil | 54,981 | 50,853 | 38,241 | 36,251 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $400 | $357 | $381 | $345 |
| EBITDA | -$24,277 | -$25,295 | -$19,160 | -$12,978 |
| % Margin | – | – | – | – |